Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 1,493Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 3MSD MERCK CO

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

CILASTATIN SODIUM; IMIPENEM; RELEBACTAM

US Patent Number : 8487093

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 212819

Patent Use Code : U-2587

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-03-21

blank

02

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

CILASTATIN SODIUM; IMIPENEM; RELEBACTAM

US Patent Number : 8487093

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 212819

Patent Use Code : U-2840

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-03-21

blank

03

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

CILASTATIN SODIUM; IMIPENEM; RELEBACTAM

US Patent Number : 8487093

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 212819

Patent Use Code : U-2586

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-03-21

blank